Harm Reduction Journal

Article	Citations
Decentralized HIV testing: comparing peer and mail-based distribution strategies to improve the reach of HIV self-testing among people who use drugs in Florida	91
Moving from ‘stigma reduction’ to ‘inclusion’: development of the inclusion collaborative at Nepean Blue Mountains Local Health District, New South Wales	83
The impact of institutionalization on the effectiveness of harm reduction: a qualitative study using drug users’ representations	64
A mixed-methods analysis of risk-reduction strategies adopted by syringe services program participants and non-syringe services program participants in New York City	59
HIV risk and prevention among clients of a delivery-based harm reduction service during an HIV outbreak among people who use drugs in northern rural Minnesota, USA	49
Exploring perceived quality of life in long-term methadone-dependent patients: a qualitative study	49
Drug checking services: barriers and facilitators to implementation by U.S. syringe services programs	48
Willingness to use and distribute HIV self-testing kits among people who inject drugs in the San Diego–Tijuana border region	40
Examining rural community pharmacists’ knowledge and practices in opioid overdose prevention and treatment services in the Southeastern United States	38
Expanding single-venue services to better engage young people who inject drugs: insights from India	34
The acceptability of overdose alert and response technologies: introducing the TPOM-ODART framework	34
Associations with experience of non-fatal opioid overdose in British Columbia, Canada: a repeated cross sectional survey study	34
Experiences of harm and mental ill-health among gay, bisexual and other men-who-have-sex-with-men who use methamphetamine or GHB/GBL in different combinations: findings from the COMeT study in Taiwan	33
Welfare first: transforming harm reduction at UK festivals	33
Assessment of two brands of fentanyl test strips with 251 synthetic opioids reveals “blind spots” in detection capabilities	32
“The people who depended on us became expendable”: Experiences of frontline workers with lived and living expertise of drug use during the COVID-19 pandemic	32
Drug decriminalization: a co-designed study outlining the implications for providers of youth services	32
Contamination of a drug consumption room with drugs and potential risks for social health care workers	32
Online interventions and virtual day centres for young people who use drugs: potential for harm reduction?	31
Fentanyl harm reduction strategies among Latinx communities in the United States: a scoping review	31
“Expected to happen”: perspectives on post-release overdose from recently incarcerated people with opioid use disorder	30
Vaping among Norwegians who smoke or formerly smoked: reasons, patterns of use, and smoking cessation activity	30
Accessing digital harm reduction services —exploring the impact of the “Here4UScotland” application	29
“Naloxone? Not for me!” First cross-assessment by patients and healthcare professionals of the risk of opioid overdose	28
Facilitators of and obstacles to practitioners’ adoption of harm reduction in cannabis use: a scoping review	28

One voice and vision: How the RISE network built a collective identity as the foundation for strategic dissemination	28
Gender and power dynamics in three types of injection partnerships among young women in rural Appalachia	27
First results of the French OCTOPUS survey among festival attendees: a latent class analysis	26
Substance use stigma reduces trust and informational support: experimental evidence across risk and relationship contexts	26
Barriers to uptake of harm reduction techniques for GBMSM who use drugs in night-clubs and sex-on-premises venues in London and the Southeast: a mixed-methods, qualitative study	26
The implementation of safer drug consumption facilities in Scotland: a mixed methods needs assessment and feasibility study for the city of Edinburgh	25
Is fentanyl in everything? Examining the unexpected occurrence of illicit opioids in British Columbia’s drug supply	25
Correction: A sea of need: provider accounts of strategies used to manage admission demands to safer opioid supply programs in Ontario	25
Strategies used to reduce harms associated with fentanyl exposure among rural people who use drugs: multi-site qualitative findings from the rural opioid initiative	25
Harm reduction in substance use: perspectives and experiences of community volunteers and student interns in Durban, South Africa	25
Channelling and taxation in European online gambling markets: evolution and policy implications	24
“To not feel fake, it can’t be fake”: co-creation of a harm reduction, peer-delivered, health-system intervention for people who use drugs	24
Will the Russian war in Ukraine unleash larger epidemics of HIV, TB and associated conditions and diseases in Ukraine?	24
Houselessness and syringe service program utilization among people who inject drugs in eight rural areas across the USA: a cross-sectional analysis	24
Safety and feasibility of intranasal heroin-assisted treatment: 4-week preliminary findings from a Swiss multicentre observational study	24
The war on drugs is a war on us: young people who use drugs and the fight for harm reduction in the Global South	24
Correction: Unintentional benzodiazepine use and frequency of drug checking service utilization: a cross-sectional study	23
Puff, Puff, Don’t Pass: harm reduction for cannabis use during a viral respiratory pandemic	23
Improving access to HIV care among people who inject drugs through tele-harm reduction: a qualitative analysis of perceived discrimination and stigma	23
Feeling safer: effectiveness, feasibility, and acceptability of continuous pulse oximetry for people who smoke opioids at overdose prevention services in British Columbia, Canada	23
Willingness to use syringe services programs in a Northern Midwest American Indian community	23
Identifying barriers and facilitators to COVID-19 vaccination uptake among People Who Use Drugs in Canada: a National Qualitative Study	23
Harm reduction behaviours and harm experiences of people who use 3,4-methylenedioxymethamphetamine (MDMA) in Aotearoa New Zealand	22
A systematic review of interventions that impact alcohol and other drug-related harms in licensed entertainment settings and outdoor music festivals	22
Counting the vulnerable: estimating the population size and assessing the HIV care continuum among women who inject drugs in Southern Mozambique	22
Spike on a bike: mobile harm reduction in action	22
Overdose risk in the context of chemsex among gay, bisexual, and other men who have sex with men	22
“There are only so many fires you can put out”: nonprofit structural constraints on service delivery for pregnant and postpartum women who use drugs in Appalachian North Georgia	22
Change in substance use among patients in opioid maintenance treatment: baseline to 1-year follow-up	21
Harm reduction engagement and ongoing opioid use among adults receiving methadone or buprenorphine in Philadelphia	21
Practical guidance for navigating buprenorphine discontinuation	21
Correction: Non-injection drug use among incarcerated people in Iran: Findings from three consecutive national bio-behavioral surveys	21
Is use of opioid agonist treatment associated with broader primary healthcare use among men with recent injecting drug use histories following release from prison? A prospective cohort study	20
Patient perspectives on naloxone receipt in the emergency department: a qualitative exploration	20
Characteristics of adverse reactions to kratom and implementation of harm reduction strategies in a sample of ethnobotanical tea bar patrons in Colorado	20
Factors associated with gaps in naloxone knowledge: evidence from a 2022 great plains survey	20
Challenges for drug checking services in Scotland: a qualitative exploration of police perceptions	19
Use and perceptions of Cannabidiol among individuals in treatment for opioid use disorder	19
Celebrating each success: proportion of remission as a measure of recovery from polysubstance use disorder proportion of remission; a recovery measure	19
Pain is associated with reduced adherence to safer injection practices among people who inject opioids	19
Reducing medical cannabis use risk among Veterans: A descriptive study	18
Evaluating the implementation and impact of harm reduction vending machines in veterans supportive housing settings: a mixed-methods study protocol	18
Assessing healthcare cost changes associated with transitioning away from cigarette smoking using healthcare claims data: an exploratory study among adult male patients with COPD	18
Leveraging mHealth interventions to reduce sex- and drug-related risk behaviors among chemsex-involved men who have sex with men: evidence from a qualitative study	18
Prevalence of HIV and Hepatitis C and access to opioid substitution treatment among people who inject drugs in three cities in Croatia: findings from the second wave of respondent-driven sampling surv	18
“It’s just what’s around these days”: social and contextual pragmatism in substance transitions	18
Correction: Developing a comprehensive inventory to define harm reduction housing	18
Feasibility of paying people who use drugs cash to distribute naloxone within their networks	18
BeHERE’s effective virtual training to build capacity to support people who use drugs in non-substance use disorder settings	18
An evaluation of first responders’ intention to refer to post-overdose services following SHIELD training	18

Structural stigma within inpatient care for people who inject drugs: implications for harm reduction	17
A qualitative study on cannabis use for harm reduction and pain among veterans enrolled in an SUD treatment program	17
“They make it too hard and too many hoops to jump”: system and organizational barriers to drug treatment during epidemic rates of opioid overdose	17
Patterns of polysubstance use among people who use drugs on an American Indian reservation of a southern plains Tribal Nation	17
Anabolic-androgenic steroid testing as a tool for consumer engagement and harm reduction: a sequential explanatory mixed-method study	17
“They won’t prosecute, but they will though:” the continuing struggle between criminalization and harm reduction within the criminal justice system in the context of an opioid overdose crisis	17
Analysis of different populations accessing online overdose response training and harm reduction supplies (ADORES)	17
International harm reduction indicators are still not reached: results from a repeated cross-sectional study on drug paraphernalia distribution in Germany, 2021	16
Injecting drugs alone during an overdose crisis in Vancouver, Canada	16
Correction: The managers’ perspectives on service providing in women’s harm reduction centers during the COVID-19 pandemic: mixed method study	16
The association between cannabis use and adherence to COVID-19 public health guidelines: prospective analyses from the French CONSTANCES cohort and SAPRIS survey	16
Not all screens are created equal: examination of surface features and other physical properties of commonly used screen materials for smoking drugs	16
Scoping evidence review on the prevention and treatment of opioid overdose	16
Managing high-risk behaviours and challenges to prevent housing loss in permanent supportive housing: a rapid review	16
The joy and pain of being a harm reduction worker: a qualitative study of the meanings about harm reduction in Brazil	15
The associations between social determinants of health, mental health, substance-use and recidivism: a ten-year retrospective cohort analysis of women who completed the connections programme in Austra	15
Feasibility, acceptability, and perceived usefulness of a community-evidence-based harm reduction intervention for sexualized stimulant use among Mexican gay, bisexual, and other men who have sex with	15
Predictors of concurrent heroin use among patients on opioid maintenance treatment in France: a multilevel study over 11 years	15
The impact of supported accommodation on health and criminal justice outcomes of people released from prison: a systematic literature review	15
Challenges in legitimizing further measures against smoking in jurisdictions with robust infrastructure for tobacco control: how far can the authorities allow themselves to go?	15
Prevalence and predictors of condom use among people who inject drugs in Georgia	15
Doctors’ and pharmacists’ perspectives on the clinical use of medicinal Cannabis: a cross-sectional study	15
Creating safe, inclusive spaces for hospital-based health care staff and people who use drugs: an exploratory qualitative study in Vancouver, Canada	14
Heroin pipe distribution to reduce high-risk drug consumption behaviors among people who use heroin: a pilot quasi-experimental study	14
Transitions from first drug use to illicit opioid and injection drug use in a multisite rural U.S. cohort of people who use drugs	14
Microbiological contamination in androgens from the black market	14
Switching behavior and changes in smoking behavior by menthol cigarette preference and menthol heated tobacco product use among adults in the United States who smoke cigarettes: an actual use study	14
Law enforcement and syringe services program implementation in rural counties in Kentucky: a qualitative exploration	14
Assessing attitudes towards elements of the overdose response hotlines/applications (ORHAs)	14
Development, acceptability and feasibility of a personalised, behavioural intervention to prevent bacterial skin and soft tissue infections among people who inject drugs: a mixed-methods Person-Based	14
The “goldfish bowl”: a qualitative study of the effects of heightened surveillance on people who use drugs in a rural and coastal Canadian setting	13
Peer-led drug checking in Chile: a case study of the country’s first harm reduction service at electronic music events	13
Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review	13
Differentiating the role of alcohol in young men’s use of substances with sex: A qualitative study	13
'It’s not going to be a one size fits all': a qualitative exploration of the potential utility of three drug checking service models in Scotland	13
Too young for medication? prescriber perspectives on how age shapes medication for opioid use disorder prescribing in transition-age adults	13
Transformative justice approaches to domestic, family, and sexual violence: a scoping review	13
Effects of a social network intervention on HIV seroconversion among people who inject drugs in Ukraine: moderation by network gender composition	13
Ultrasound-guided phlebotomy in primary care for people who inject drugs	13
Come back when you’re infected: pharmacy access to sterile syringes in an Arizona Secret Shopper Study, 2023	13
Predictors of COVID-19 vaccine uptake and preferences for service delivery among people who inject drugs accessing a syringe service program	13
How an emergency department is organized to provide opioid-specific harm reduction and facilitators and barriers to harm reduction implementation: a systems perspective	13
The potential use of digital technologies to enhance opioid agonist treatment in rural and remote communities of British Columbia, Canada	13
Involuntary discharge from drug or alcohol treatment programs in Vancouver, Canada	13
“I feel like marijuana is the only drug that wouldn’t kill me”: perceptions of cannabis use in previously incarcerated Black men who have sex with other men	13
Preloading with drugs before entry to the nighttime entertainment district: presentation, intoxication rates, and effects of police presence during assessment	13
Correction: A reduced exposure heated tobacco product was introduced then abruptly taken off United States shelves: results from a tobacco harm reduction natural experiment	13
Sterile syringe availability in Georgia pharmacies remained rare, despite policy change permitting sales	13
A scoping review on barriers and facilitators to harm reduction care among youth in British Columbia, Canada	13
Correction: Economic evaluation of the effect of needle and syringe programs on skin, soft tissue, and vascular infections in people who inject drugs: a microsimulation modelling approach	13
Quantifying the size and characteristics of a population of people who use drugs on the reservation lands of a tribal nation in the southern plains (USA)	13
HIV vaulnerability among people who inject drugs (PWID): findings from the Bangladesh integrated biological and behavioural surveillance (IBBS) study 2020	13
Best practices for first psychedelic experiences: harm reduction advice from the psychedelic community	13
Oral health risks in adults who use electronic nicotine delivery systems and oral nicotine pouches: a critical review of the literature and qualitative synthesis of the available evidence	12
Withdrawal during outpatient low dose buprenorphine initiation in people who use fentanyl: a retrospective cohort study	12
Developing and testing a digital harm reduction app for GBMSM engaging in chemsex: a feasibility study grounded in users' lived experiences	12
Perspectives of U.S. harm reduction advocates on persuasive message strategies	12
Correction: Health workers’ perspectives of hepatitis B-related stigma among Aboriginal and Torres Strait Islander people in New South Wales, Australia	12
50 years of harm reduction in Europe: high time for transformation	12
Public health impact and harm reduction implications of xylazine-involved overdoses: a narrative review	12
Xylazine co-occurrence with illicit fentanyl is a growing threat in the Deep South: a retrospective study of decedent data	12
Scaling up low barrier wound care for people who use drugs: a mixed methods study	12
Challenges for the implementation of injectable opioid agonist treatment: a scoping review	12
Support from New York City’s office of chief medical examiner for people bereaved by drug poisoning: development and implementation of the family support program	12
“That would be such a game changer”: a qualitative study of the acceptability and feasibility of a digital harm reduction support tool among people who use drugs	12
A Case report of a continuous ambulatory drug delivery (CADD) pump to deliver opioid agonist treatment in an acute care setting	12
High prevalence of hepatitis B virus susceptibility among persons undergoing community-based hepatitis C virus treatment	12
“I don’t let anybody die on my watch”: perspectives on the intersection of community overdose response and emergency medical services among people who use drugs in Seattle, WA	12
The motives and methods of methamphetamine and ‘heroin’ co-use in West Virginia	11
Cannabis products and risk perceptions among people who consume and do not consume cannabis in the UK: findings from the International Cannabis Policy Study	11
The impact of JUUL market entry on cigarette sales: evidence from a major chain retailer in Canada	11
NPAideS: a drug-checking study among 3-methylmethcathinone (3-MMC) users	11
Informed implementation practice – formative research of a mobile drug consumption room in Brno, Czech Republic	11
The quality and scope of health information on online drug platforms: a topic modelling and expert evaluation study of a Polish-language forum	11
HIV prevalence and continuum of care among incarcerated people in Iran from 2010 to 2017	11
The quality of health information provided on web sites selling cannabis to consumers in Canada is poor	11
Social justice with harm reduction approaches for mothers who use opioids: an international comparative ethnographic study with community engaged methods	11
‘We don’t live in a harm reduction world, we live in a prohibition world’: tensions arising in the design of drug alerts	11
Risk reduction behaviours following the detection of unexpected drugs through community drug checking: a cross-sectional study	11
“I don’t want to die”: a qualitative study of coping strategies to prevent fentanyl-related overdose deaths among people who inject drugs and its implications for harm reduction policies	11

A simplified point-of-service model for hepatitis C in people who inject drugs in South Africa	11
Exploring substance use disorder discussions in Native American communities: a retrospective Twitter infodemiology study	11
Impact of Spanish gambling regulations on online gambling behavior and marketing strategies	10
Relational anonymity in reducing the harms of illicit drug use: accounts of users of dark web- and street-based services in Finland	10
Understanding the role of overdose witnesses: responses and characteristics of people who inject drugs in Oakland and San Francisco	10
The potential of new nicotine and tobacco products as tools for people who smoke to quit combustible cigarettes – a systematic review of common practices and guidance towards a robust study protocol t	10
“We knew it was coming: we didn’t act” perspectives from people who use drugs and substance use workforce on the impact of delays in implementation of the supervised injection facility and drug checki	10
Exploring the perception of key stakeholders toward khat policy approaches in Ethiopia: a qualitative study	10
Selling sex in the context of substance use: social and structural drivers of transactional sex among men who use opioids in Maryland	10
Correction: Reducing the harms of xylazine: clinical approaches, research deficits, and public health context	10
Legal sourcing of ten cannabis products in the Canadian cannabis market, 2019–2021: a repeat cross-sectional study	10
Challenges of the COVID-19 pandemic on women’s HIV harm reduction centers: a mixed-methods study	10
Opioid overdose prevention education in Texas during the COVID-19 pandemic	10
Posttraumatic stress disorder in people who use drugs: syringe services program utilization, treatment need, and preferences for onsite mental health care	10
National review of state laws on opioid antagonists in Kindergarten-12th grade schools across the United States	10
Patient perceptions of and experiences with stigma using telehealth for opioid use disorder treatment: a qualitative analysis	10
Exploring the impact of the COVID-19 pandemic on healthcare and substance use service access among women who inject drugs: a qualitative study	10
Differences by race and ethnicity in drug use patterns, harm reduction practices and barriers to treatment among people who use drugs in Rhode Island	10
Supporting syringe services programs in the initiation and scale-up of vaccine administration: findings from in-depth interviews	10
Progress and challenges in the elimination of hepatitis C among people who inject drugs in Germany: results of a pilot study for a national monitoring system, 10 years after the first data collection	10
“We want everything in a one-stop shop”: acceptability and feasibility of PrEP and buprenorphine implementation with mobile syringe services for Black people who inject drugs	10
Non-disclosure of drug injection practices as a barrier to HCV testing: results from the PrebupIV community-based research study	10
Nurse prescribing practices across the globe for medication-assisted treatment of the opioid use disorder (MOUD): a scoping review	10
Bigger than sport: the enhanced games and the commodification of telehealth, testosterone, and dependency	10
SARS-CoV-2 antibody prevalence, correlates, and access to harm reduction services among people who inject drugs living with and without HIV and their partners in Kenya	10
Vancouver’s Alcohol Knowledge Exchange: lessons learned from creating a peer-involved alcohol harm reduction strategy in Vancouver’s Downtown Eastside	10
Suicidal thoughts and behaviors among untreated illicit substance users: a population-based study	9
Peer-assisted telemedicine for hepatitis C intervention in people experiencing housing instability	9
Common data elements for criminal legal system involvement for people who use drugs	9
E-cigarette use and smoking-related disparities in England: an observational study using small area estimation and nonparametric regression	9
Point-of-care community drug checking technologies: an insider look at the scientific principles and practical considerations	9
Evaluation of nitazene immunoassay test strips for rapid in-situ detection of nitazene and nitazene analogs in illicit drug samples	9
Philanthropic donor perspectives about providing harm reduction services for people living with HIV/AIDS in a hospital setting	9
Comprehensive drug policies increase trust in local government: an analysis of authorities’ and residents’ perspectives in rural US Appalachian and Midwestern counties	9
Overdose responses among rural people who use drugs: A multi-regional qualitative study	9
Community coalition’s diversity and targeted overdose prevention strategies designed to reach special populations	9
“Because we’re the experts”: centering the expertise of people who use drugs to identify and propose solutions for overdose prevention	9
Managing risks and harms associated with the use of anabolic steroids: a qualitative study	9
Muslims perceptions of safe alcohol use: a qualitative study in the Gulf Council Cooperation countries	9
Women, gender and drugs: between research and action	9
Harm reduction among refugees and displaced populations in Lebanon: a systematic review	9
Patterns of care contacts in the final year of life among opioid overdose fatalities in southern Sweden: a latent class analysis	9
What we need, not what we’re given: recommendations for action from young sex workers who use drugs	9
Street drug monitoring with networked spectrometers powered by machine learning: a pilot study in Ontario, Canada	9
A novel model of care; Telemedicine and peer support for HCV care among HIV-infected people who inject drugs in remote Myanmar: a retrospective study	9
The impact of psychostimulant use on office based buprenorphine treatment retention	9
Mandatory verses voluntary self-tests for new online casino customers: effect on engagement, quality, gambling behavior and use of responsible gambling measures	9
COVID-19 vaccination intention among people who use drugs in France in 2021: results from the international community-based research program EPIC	9
The geography of risk: understanding disparities in nonmedical opioid mortality and the role of socio-built environments in New Jersey	9
Reducing the harms of cannabis use in youth post-legalization: insights from Ontario youth, parents, and service providers	9
Implementing Canada’s first national virtual phone based overdose prevention service: lessons learned from creating the National Overdose Response Service (NORS)	8
Neo-colonialism and financing for the war on drugs: a review of current policy and recommendations for countries in the global north	8
A confirmed case of xylazine-induced skin ulcers in a person who injects drugs in Miami, Florida, USA	8
‘Why would we not want to keep everybody safe?’ The views of family members of people who use drugs on the implementation of drug consumption rooms in Scotland	8
Supervised on-site dosing in injectable opioid agonist treatment-considering the patient perspective. Findings from a cross-sectional interview study in two German cities	8
Emergence of synthetic drugs in South America: insights from Brazil, Chile, and Colombia	8
Ups and downs of addiction harm reduction in Iran: key insights and implications for harm reduction policy and policing	8
Perceptions of stigma of pregnant individuals experiencing substance use disorder receiving prenatal care at magdalene clinic: a cross-sectional study	8
Innovations at the intersection of homelessness and substance use during the COVID-19 pandemic: a scoping review	8
“No-one just does drugs during business hours!”: evaluation of a 24/7 primary needle and syringe program in St Kilda, Australia	8
An exploration of desired abstinent and non-abstinent recovery outcomes among people who use methamphetamine	8
Leveraging lived experience: a qualitative study on the impact of formerly incarcerated consultants in public policy making to improve safety net services	8
Sexual violence at Australian universities: intersectionality in policy and practice	8
Moral foundations and attitudes towards supervised consumption services: a regional moderation study	8
Peer research with populations of people who use street tablets in areas over-represented by drug-related harms in the UK: a case study	8
Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive ev	8
CENTER-ing Black voices: incorporating lived experience across the research process to advance equity in drug treatment and outcomes	8
Acceptability and usability of a respiratory biosensor for drug overdose detection and first responder notification: a qualitative evaluation of perspectives from people who use drugs and wider stakeh	8
Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities	8
Community pharmacists’ attitudes toward and practice of pharmacy-based harm reduction services in Pittsburgh, PA: a descriptive survey	8
Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022–2023 (CAMS-22)	7
A scoping review of implementation considerations for harm reduction vending machines	7
Integrating harm reduction interventions for older adults in opioid treatment programs: a qualitative study of patient and provider perspectives	7
Exploration of novel harm reduction approaches to increase client engagement (ENHANCE): protocol for a prospective cohort study	7
Naloxone prescriptions among patients with a substance use disorder and a positive fentanyl urine drug screen presenting to the emergency department	7
Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service delivery	7
Estimating lung cancer risk from e-cigarettes and heated tobacco products: applications of a tool based on biomarkers of exposure and of potential harm	7
Substance use, injection risk behaviors, and fentanyl-related overdose risk among a sample of PWID post-Hurricane Maria	7
Assessment of harm reduction receipt and infectious diseases outcomes in United States Veterans with opioid use disorder and history of injection drug use	7
“As safe as possible”: a qualitative study of opioid withdrawal and risk behavior among people who use illegal opioids	7
Fanning the flame: analysing the emergence, implications, and challenges of Australia’s de facto war on Nicotine	7
An individual-based dynamic model to assess interventions to mitigate opioid overdose risk	7
People who inject oral morphine favor experimentation with injectable opioid substitution	7
Repeated point-prevalence of switching away from smoking after electronic nicotine delivery systems (ENDS) purchase	7
Balancing public health and privacy rights: a mixed-methods study on disclosure obligations of people living with HIV to their partners in China	7
Long-acting injectable depot buprenorphine from a harm reduction perspective in patients with ongoing substance use and multiple psychiatric comorbidities: a qualitative interview study	7
Association between socioeconomic and motherhood characteristics with receiving community-based treatment services among justice-involved young female drug users: a retrospective cohort study in Taiwa	7
Drug preparation, injection-related infections, and harm reduction practices among a national sample of individuals entering treatment for opioid use disorder	7
HOME protocol for a national online survey of people who inject drugs	7
Correction: Assessing feasibility of a modified same-day test-and-treat model for hepatitis C among rural people who inject drugs	7
Difficulty accessing supervised consumption services during the COVID-19 pandemic among people who use drugs in Vancouver, Canada	7
Self-exclusion and breaching of self-exclusion from gambling: a repeated survey study on the development of a nationwide self-exclusion service	7
Crack/cocaine use to manage xylazine exposure in fentanyl in Connecticut: findings from a convergent mixed methods study	7
Chiral sensitivity of medetomidine lateral flow immunoassay test strips	7
Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the O	7